Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: Updated analysis of 51 patients-authors' response

Journal of Antimicrobial Chemotherapy

Volumn 67, Issue 8, 2012, Pages 2056-2057

  Koh, Won Jung ^a   Shim, Tae Sun ^b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

MDR; Oxazolidinones; TB; XDR

Indexed keywords

LINEZOLID; OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; HUMAN; LETTER; MULTIDRUG RESISTANT TUBERCULOSIS; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 84864512573     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dks211     Document Type: Letter

References (10)

1. Bolhuis MS, van Altena R, Alffenaar JW. Comment on: Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients. J Antimicrob Chemother 2012; 67: 2055-7.
2. Koh WJ, Kang YR, JeonK et al.Daily 300 mg dose of linezolid formultidrugresistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients. J Antimicrob Chemother 2012; 67: 1503-7.
3. Cox H, Ford N. Linezolid for the treatment of complicated drugresistant tuberculosis: a systematic review and meta-analysis. Int J Tuberc Lung Dis 2012; 16: 447-54.
4. Sotgiu G, Centis R, D'Ambrosio L et al. Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis. Eur Respir J 2012; doi:10.1183/09031936. 00022912.
5. Lee M, Min J, Carroll M et al. Clinical trial of the efficacy of linezolid in XDR pulmonary tuberculosis. Int J Tuberc Lung Dis 2010; 14 Suppl 2: S56-7 (abstract).
6. Carroll MW, Lee MS, Song TS et al. Linezolid for extensively drug resistant pulmonary tuberculosis. Am J Respir Crit Care Med 2011; 183: A1838 (abstract).
7. Carroll MW, Choi H, Min S et al. Rhabdomyolysis in a patient treated with linezolid for extensively drug-resistant tuberculosis. Clin Infect Dis 2012; 54: 1624-7.
8. Koh WJ, Kwon OJ, Gwak H et al. Daily 300 mg dose of linezolid for the treatment of intractable multidrug-resistant and extensively drugresistant tuberculosis. J Antimicrob Chemother 2009; 64: 388-91.
9. Park IN, Hong SB, Oh YM et al. Efficacy and tolerability of daily-half dose linezolid in patients with intractable multidrug-resistant tuberculosis. J Antimicrob Chemother 2006; 58: 701-4.
10. Nam HS, Koh WJ, Kwon OJ et al. Daily half-dose linezolid for the treatment of intractable multidrug-resistant tuberculosis. Int J Antimicrob Agents 2009; 33: 92-3.